Author

Ronnie P. Kasirye

Observed names: Kasirye, Ronnie, R. Kasirye, Ronnie Kasirye

Institutions: MUJHU Research Collaboration, Makerere University

Observed institutions: Johns Hopkins University, University of the Witwatersrand, London School of Hygiene & Tropical Medicine, MRC Clinical Trials Unit at UCL, Infectious Diseases Institute, MUJHU Research Collaboration, MRC/UVRI & LSHTM Uganda Research Unit, University College London, Makerere University, Wellcome Trust, Uganda Virus Research Institute, University of KwaZulu-Natal

ORCID: 0000-0002-5200-464X

Observed ORCID: 0000-0002-5200-464X

OpenAlex ID: A5086489360

Relationship between socioeconomic status and risk of sexually transmitted infections in Uganda: Multilevel analysis of a nationally representative survey

2018 · Godwin Anguzu, Andrew Flynn, et al. · International Journal of STD & AIDS · 41

High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy

2013 · Ravindra K. Gupta, Ruth L. Goodall, et al. · Clinical Infectious Diseases · 37

PDF

Acceptability of a Mobile Phone Support Tool (Call for Life Uganda) for Promoting Adherence to Antiretroviral Therapy Among Young Adults in a Randomized Controlled Trial: Exploratory Qualitative Study

2021 · Adelline Twimukye, Agnes Bwanika Naggirinya, et al. · JMIR mhealth and uhealth · 33

PDF

Re-engagement in HIV care following a missed visit in rural Uganda

2018 · Maria Sarah Nabaggala, Rosalind Parkes-Ratanshi, et al. · BMC Research Notes · 30

PDF

Malaria parasitemia among blood donors in Uganda

2020 · Kristin J. Murphy, Andrea L. Conroy, et al. · Transfusion · 28

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe

2012 · Antonieta Medina Lara, Jesse Kigozi, et al. · PLoS ONE · 27

PDF

Factors associated with caretakers’ knowledge, attitude, and practices in the management of pneumonia for children aged five years and below in rural Uganda

2023 · Dan Kajungu, Betty Nabukeera, et al. · BMC Health Services Research · 22

PDF

Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial

2018 · Zacchaeus Anywaine, Jonathan Levin, et al. · PLoS ONE · 21

PDF

The Mirasol Evaluation of Reduction in Infections Trial (MERIT): study protocol for a randomized controlled clinical trial

2022 · Ronnie Kasirye, Heather A. Hume, et al. · Trials · 18

PDF

Lopinavir/Ritonavir Monotherapy after 24 Weeks of Second-Line Antiretroviral Therapy in Africa: A Randomized Controlled Trial (Sara)

2012 · Charles F Gilks, A Sarah Walker, et al. · Antiviral Therapy · 18

Cost Effectiveness Analysis of Routine Laboratory or Clinically Driven Strategies for Monitoring Anti-Retroviral Therapy in Uganda and Zimbabwe (DART Trial)

2009 · A. Medina Lara, Jesse Kigozi, et al. · 18

Effect of cotrimoxazole prophylaxis on malaria occurrence in HIV ‐infected patients on antiretroviral therapy in sub‐Saharan Africa

2015 · R. Kasirye, K. Baisley, et al. · Tropical Medicine & International Health · 15

SARS‐CoV ‐2 seroprevalence among blood donors in Uganda: 2019–2022

2023 · Evan M. Bloch, Dorothy Kyeyune, et al. · Transfusion · 14

PDF

Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy

2015 · Ronnie P. Kasirye, Kathy Baisley, et al. · AIDS · 14

Effect of antiretroviral therapy on malaria incidence in HIV-infected Ugandan adults

2016 · Ronnie P. Kasirye, Heiner Grosskurth, et al. · AIDS · 13

Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design

2015 · Zacchaeus Anywaine, Andrew Abaasa, et al. · Contemporary Clinical Trials · 12

High Level of Viral Suppression and Low Switch Rate to Second-Line Antiretroviral Therapy among HIV-Infected Adult Patients Followed over Five Years: Retrospective Analysis of the DART Trial

2014 · Cissy Kityo, Diana M. Gibb, et al. · PLoS ONE · 10

PDF

Supporting Information S1

2010 · A. Medina Lara, Jesse Kigozi, et al. · 6

Exit interviews administered to patients participating in the COSTOP placebo controlled randomised trial in Uganda

2016 · Andrew Nunn, Zacchaeus Anywaine, et al. · Contemporary Clinical Trials Communications · 5

PDF

Attitudes and perceptions towards developing a health educational video to enhance optimal uptake of malaria preventive therapy among pregnant women in Uganda: a qualitative study involving pregnant women, health workers, and Ministry of health officials

2024 · Rita Nakalega, Ruth Nabisere-Arinaitwe, et al. · BMC Health Services Research · 3

PDF

Longitudinal effect of CD4 by cotrimoxazole use on malaria incidence among HIV-infected Ugandan adults on antiretroviral therapy: a randomized controlled study

2016 · Ronnie Kasirye, Heiner Grosskurth, et al. · Malaria Journal · 3

PDF

Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda

2014 · R. L. Goodall, D. T. Dunn, et al. · Journal of Antimicrobial Chemotherapy · 3

PDF

Kaposi's sarcoma herpesvirus seroprevalence among blood donors in Uganda

2025 · Tait Huso, Jodie L. White, et al. · Transfusion · 2

A Model for Estimating the Burden of Disease of Transfusion-Transmitted Infection

2024 · William Riley, Kailey Love, et al. · International Journal of Public Health · 2

PDF

Validation of anthropometric-based weight prediction equations among Ugandan adults: A Cross-sectional study

2025 · Zakaria Mukasa, Juliet Mutanda Ntuulo, et al. · PLoS ONE · 1

Works count: 37

Citation count: 397

H-index: 14

I10-index: 17